APA (7th ed.) Citation

Galusic, D., Krecak, I., Blaslov, V., Opara, A. K., Valkovic, T., & Kinda, S. B. Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma? MDPI AG.

Chicago Style (17th ed.) Citation

Galusic, Davor, Ivan Krecak, Viktor Blaslov, Andela Krstulovic Opara, Toni Valkovic, and Sandra Basic Kinda. Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma? MDPI AG.

MLA (9th ed.) Citation

Galusic, Davor, et al. Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma? MDPI AG.